GlassScriptPhysician profile
Crystal S Gilbert
NPI 1134406531
$6,207.49
in general payments reported to CMS, 2019-2025
39 companies · $838 in 2025
The $838 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,097 · 2022: $1,616 · 2023: $1,320 · 2024: $1,337 · 2025: $838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,445 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,444.92 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,214.20 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $684.91 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $683.92 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $638.89 | 2021-2025 | |
| Glaxosmithkline, LLC. | $570.96 | 2021-2025 | Trelegy Ellipta, Bexsero, Arexvy |
| Novo Nordisk INC | $478.01 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $237.90 | 2021-2023 | Gattex |
| Janssen Pharmaceuticals, INC | $213.35 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $127.01 | 2022-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $101.73 | 2024-2025 | Fanapt |
| Sanofi-Aventis U.S. LLC | $94.61 | 2022-2025 | |
| Kowa Pharmaceuticals America, INC. | $88.32 | 2023 | Seglentis |
| Teva Pharmaceuticals USA, INC. | $84.03 | 2021-2024 | Ajovy, Austedo |
| Astellas Pharma US INC | $78.20 | 2022-2023 | Myrbetriq, Veozah |
| Axsome Therapeutics, INC. | $71.45 | 2022-2024 | Auvelity |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.